InnoSign

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Signase

This biotechnology company develops small molecule inhibitors of cell replication pathways to treat cancer patients by inhibiting tumour growth.

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.

Spotlight Medical

This company develops AI-driven prognosis tests to help oncologists select the most effective treatments for cancer patients.

Oncosyne

This company develops patient-derived tumoroid drug screening platforms for pharmaceutical firms and oncologists to improve drug discovery and personalised cancer treatment.

Ariz Precision Medicine

The company develops targeted nanoparticle and siRNA therapies for cancer patients and pharmaceutical partners.

OncoPrecision

The company develops patient-derived micro-avatar models and therapeutic antibodies to provide oncology drug discovery and precision medicine services for pharmaceutical partners and clinicians.

Inbiomotion

This company develops a gene expression biomarker test to help oncologists select early breast cancer patients for adjuvant treatment with bisphosphonates.